Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Indian J Exp Biol ; 49(7): 534-9, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21800504

ABSTRACT

Makaradhwaja, an alchemical Ayurvedic mercury preparation is used as stimulant and vitalizer. Towards veterinary practices, the acceptability, tolerability and toxicity studies were undertaken in geriatric pet dogs aged more than 10 years irrespective of breed and sex for future use. Makaradhwaja (2.5 mg/kg) was used with honey once daily for 30 days. Before and after treatment, blood was collected for hematological studies as well as liver, kidney function and anti-oxidant activity. In control group, honey itself showed no appreciable change whereas, Makaradhwaja lowered neutrophil and total leucocyte count. Serum cholesterol, urea, glucose, alanine amino transferase, aspartate amino transferase, sodium, phosphorus and calcium were decreased. Haemoglobin and serum creatinine were significantly increased. There was appreciable physical, behavioral and body weight change including quality of life. The dose was used in replication of human dose (125 mg/50 kg). Anti-oxidant study showed significant increase of lipid per oxidation in experimental group while the values of ABTS radical cation decolorisation assay although decreased but did not show any significant changes. Decrease of serum urea and increase of serum creatinine could not be explained on single dose response. Different dose study could only explain the optimum dose to be required in canine practices.


Subject(s)
Aging/drug effects , Medicine, Ayurvedic , Mercury Compounds/pharmacology , Aging/blood , Aging/psychology , Animals , Antioxidants/metabolism , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid , Dogs , Honey , Kidney Function Tests , Liver Function Tests , Mercury Compounds/administration & dosage , Mercury Compounds/toxicity
2.
Andrologia ; 42(1): 48-56, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20078516

ABSTRACT

The safety and spermatogenic activity of processed Shilajit (PS) were evaluated in oligospermic patients. Initially, 60 infertile male patients were assessed and those having total sperm counts below 20 million ml(-1) semen were considered oligospermic and enrolled in the study (n = 35). PS capsule (100 mg) was administered twice daily after major meals for 90 days. Total semenogram and serum testosterone, luteinising hormone and follicle-stimulating hormone were estimated before and at the end of the treatment. Malondialdehyde (MDA), a marker for oxidative stress, content of semen and biochemical parameters for safety were also evaluated. Twenty-eight patients who completed the treatment showed significant (P < 0.001) improvement in spermia (+37.6%), total sperm count (+61.4%), motility (12.4-17.4% after different time intervals), normal sperm count (+18.9%) with concomitant decrease in pus and epithelial cell count compared with baseline value. Significant decrease of semen MDA content (-18.7%) was observed. Moreover, serum testosterone (+23.5%; P < 0.001) and FSH (+9.4%; P < 0.05) levels significantly increased. HPLC chromatogram revealed inclusion of PS constituents in semen. Unaltered hepatic and renal profiles of patients indicated that PS was safe at the given dose. The present findings provide further evidence of the spermatogenic nature of Shilajit, as attributed in Ayurvedic medicine, particularly when administered as PS.


Subject(s)
Medicine, Ayurvedic , Oligospermia/drug therapy , Spermatogenesis/drug effects , Adult , Follicle Stimulating Hormone/blood , Humans , India , Luteinizing Hormone/blood , Male , Oxidative Stress/drug effects , Sperm Count , Testosterone/blood , Treatment Outcome
3.
J Ethnopharmacol ; 84(2-3): 131-8, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12648805

ABSTRACT

A number of Indian medicinal plants have been used for thousands of years in the traditional system of medicine (Ayurveda). Amongst these are plants used for the management of neurodegenerative diseases such as Parkinson's, Alzheimer's, loss of memory, degeneration of nerves and other neuronal disorders by the Ayurvedic practitioners. Though the etiology of neurodegenerative diseases remains enigmatic, there is evidence, which indicates that defective energy metabolism, excitotoxicity and oxidative damage may be crucial factors (Ann. Neurol. 38 (3) (1995) 357). The part of the Ayurvedic system that provides an approach to prevention and treatment of degenerative diseases is known as Rasayana, and plants used for this purpose are classed as rejuvenators. This group of plants generally possesses strong antioxidant activity (Pharmacol. Biochem. Behav. 43 (1992) 1175), but only a few have been investigated in detail. In the present study, three such rasayana plants were tested for the first time for their toxicity and free radical scavenging activity both in vitro and ex vivo. All the three plant infusions (up to 1 mg/ml) showed no toxic effects on the viability of PC12 cell line as judged by MTT-test. Both ethanolic extracts and water infusions of the plants were tested for their antioxidant activity in the 2,2'-azinobis-3-ethyl-benzothiazoline-6-sulfonic acid (ABTS*(+)) radical cation decolorization assay; inhibition of lipid peroxidation by plant infusions was carried out using spontaneous lipid peroxidation of rat brain homogenate, and IC50 values were determined. The results from the ABTS assay showed that the ethanolic extract of Sida cordifolia was found to be most potent (IC50 16.07 microg/ml), followed by Evolvulus alsinoides (IC50 33.39 microg/ml) and Cynodon dactylon (IC50 78.62 microg/ml). The relative antioxidant capacity for the water infusions was observed in the following order: E. alsinoides (IC50 172.25 microg/ml)>C. dactylon (IC50 273.64 microg/ml)>S. cordifolia (IC50 342.82 microg/ml). The results of water infusions of the plants on lipid peroxidation were as follows: E. alsinoides (IC50 89.23 microg/ml)>S. cordifolia) (IC50 126.78 microg/ml)>C. dactylon (IC50 608.31 microg/ml).


Subject(s)
Antioxidants/pharmacology , Neurodegenerative Diseases/therapy , Phytotherapy , Plants, Medicinal/chemistry , Animals , Benzothiazoles , Brain Chemistry/drug effects , Convolvulaceae/chemistry , Cynodon/chemistry , Ethanol , Humans , In Vitro Techniques , India , Lipid Peroxidation/drug effects , Malvaceae/chemistry , Medicine, Ayurvedic , PC12 Cells , Rats , Solvents , Sulfonic Acids/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Water
4.
J Ethnopharmacol ; 80(2-3): 147-53, 2002 May.
Article in English | MEDLINE | ID: mdl-12007704

ABSTRACT

From ancient times, Swarnabhasma (gold ash) has been used in several clinical manifestations including loss of memory, defective eyesight, infertility, overall body weakness and incidence of early aging. Swarnabhasma has been used by Ayurvedic physicians to treat different diseases like bronchial asthma, rheumatoid arthritis, diabetes mellitus, nervous disorders, etc. In the present investigation, Swarnabhasma was prepared after proper purification and calcination as per Ayurvedic pharmacy which consisted of Realger (As(2)S(2)), Lead oxide (Pb(3)O(4)), Pure gold (Au) and Latex of Calotropis gigantea. Qualitative analyses indicated that Swarnabhasma contained not only gold but also several microelements (Fe, Al, Cu, Zn, Co, Mg, Ca, As, Pb, etc.). Infrared spectroscopy showed that the material was free from any organic compound. The metal content in the bhasma was determined by atomic absorption spectrometry. Acute oral administration of Swarnabhasma showed no mortality in mice (up to 1 ml /20 g b.w. of Swarnabhasma suspension containing 1mg of drug). Chronic administration of Swarnabhasma also showed no toxicity as judged by SGPT, SGOT, serum creatinine and serum urea level and histological studies. In an experimental animal model, chronic Swarnabhasma-treated animals showed significantly increased superoxide dismutase and catalase activity, two enzymes that reduce free radical concentrations in the body.


Subject(s)
Free Radical Scavengers/chemistry , Gold/chemistry , Latex/chemistry , Animals , Arsenic , Body Weight/drug effects , Calotropis , Catalase/metabolism , Drug Combinations , Free Radical Scavengers/toxicity , Gold/toxicity , Kidney/drug effects , Kidney/pathology , Latex/toxicity , Lead , Liver/drug effects , Liver/pathology , Male , Medicine, Ayurvedic , Mice , Spectrophotometry, Atomic , Spectrophotometry, Infrared/methods , Superoxide Dismutase/metabolism , Toxicity Tests, Acute
5.
Toxicon ; 32(12): 1551-7, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7725324

ABSTRACT

An organic acid, isolated and purified from the root extract of an Indian medicinal plant sarsaparilla Hemidesmus indicus R. Br, possessed viper venom inhibitory activity. The compound (designated HI-RVIF) was isolated by solvent extraction, silica gel column chromatography and thin layer chromatography, and was homogeneous in nature. The white needle-shaped crystals were soluble in water, methanol and chloroform and had a melting point of 155-158 degrees C and lambda max 260 nm. Spectral analysis confirmed the presence of a benzene ring, methoxy group, and hydroxyl group; the mol. wt of the compound was 168. HI-RVIF significantly antagonized viper venom-induced lethal, haemorrhagic, coagulant and anticoagulant activity in experimental rodents.


Subject(s)
Antivenins/isolation & purification , Carboxylic Acids/isolation & purification , Plant Extracts/isolation & purification , Plants, Medicinal/chemistry , Viper Venoms/antagonists & inhibitors , Animals , Antivenins/chemistry , Antivenins/pharmacology , Antivenins/therapeutic use , Carboxylic Acids/chemistry , Carboxylic Acids/pharmacology , Chloroform/chemistry , Chromatography, Thin Layer , Disease Models, Animal , Hemorrhage/chemically induced , Hemorrhage/therapy , India , Lethal Dose 50 , Male , Methanol/chemistry , Mice , Molecular Weight , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Roots/chemistry , Snake Bites/therapy , Spectrophotometry, Infrared , Viper Venoms/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL